BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jadidi-Niaragh F, Mirshafiey A. Histamine and histamine receptors in pathogenesis and treatment of multiple sclerosis. Neuropharmacology 2010;59:180-9. [PMID: 20493888 DOI: 10.1016/j.neuropharm.2010.05.005] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 del Rio R, Noubade R, Saligrama N, Wall EH, Krementsov DN, Poynter ME, Zachary JF, Thurmond RL, Teuscher C. Histamine H4 receptor optimizes T regulatory cell frequency and facilitates anti-inflammatory responses within the central nervous system. J Immunol 2012;188:541-7. [PMID: 22147765 DOI: 10.4049/jimmunol.1101498] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 4.2] [Reference Citation Analysis]
2 Jadidi-niaragh F, Mirshafiey A. The deviated balance between regulatory T cell and Th17 in autoimmunity. Immunopharmacology and Immunotoxicology 2012;34:727-39. [DOI: 10.3109/08923973.2011.619987] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 3.7] [Reference Citation Analysis]
3 Zhou S, Huang G, Chen G. The antagonistic activity of H1 receptor antagonists as medicinal foods. Trends in Food Science & Technology 2020;105:1-16. [DOI: 10.1016/j.tifs.2020.08.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
4 Zhou S, Huang G, Chen G. Design, synthesis and biological activity of a novel ethylenediamine derivatives as H1 receptor antagonists. Bioorg Med Chem 2019;27:115127. [PMID: 31703894 DOI: 10.1016/j.bmc.2019.115127] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Zhou S, Huang G. Synthesis of anti-allergic drugs. RSC Adv 2020;10:5874-85. [DOI: 10.1039/c9ra10659f] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ghamari N, Zarei O, Arias-Montaño JA, Reiner D, Dastmalchi S, Stark H, Hamzeh-Mivehroud M. Histamine H3 receptor antagonists/inverse agonists: Where do they go? Pharmacol Ther 2019;200:69-84. [PMID: 31028835 DOI: 10.1016/j.pharmthera.2019.04.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
7 Saligrama N, Noubade R, Case LK, del Rio R, Teuscher C. Combinatorial roles for histamine H1-H2 and H3-H4 receptors in autoimmune inflammatory disease of the central nervous system. Eur J Immunol 2012;42:1536-46. [PMID: 22678907 DOI: 10.1002/eji.201141859] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
8 Jadidi-niaragh F, Mirshafiey A. Regulatory T-cell as orchestra leader in immunosuppression process of multiple sclerosis. Immunopharmacology and Immunotoxicology 2010;33:545-67. [DOI: 10.3109/08923973.2010.513391] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
9 Jadidi-Niaragh F, Mirshafiey A. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis. Scand J Immunol 2011;74:1-13. [PMID: 21338381 DOI: 10.1111/j.1365-3083.2011.02536.x] [Cited by in Crossref: 251] [Cited by in F6Publishing: 236] [Article Influence: 22.8] [Reference Citation Analysis]
10 Stamoula Ε, Ainatzoglou A, Stamatellos V, Dardalas I, Siafis S, Matsas A, Stamoulas K, Papazisis G. Atypical antipsychotics in multiple sclerosis: A review of their in vivo immunomodulatory effects. Multiple Sclerosis and Related Disorders 2022;58:103522. [DOI: 10.1016/j.msard.2022.103522] [Reference Citation Analysis]
11 Shteinikov VY, Korosteleva AS, Tikhonova TB, Potapieva NN, Tikhonov DB. Ligands of histamine receptors modulate acid-sensing ion channels. Biochem Biophys Res Commun 2017;490:1314-8. [PMID: 28688766 DOI: 10.1016/j.bbrc.2017.07.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
12 Rhead B, Shao X, Graves JS, Chitnis T, Waldman AT, Lotze T, Schreiner T, Belman A, Krupp L, Greenberg BM, Weinstock-Guttman B, Aaen G, Tillema JM, Rodriguez M, Hart J, Caillier S, Ness J, Harris Y, Rubin J, Candee MS, Gorman M, Benson L, Mar S, Kahn I, Rose J, Casper TC, Quach H, Quach D, Schaefer C, Waubant E, Barcellos LF; US Network of Pediatric MS Centers. miRNA contributions to pediatric-onset multiple sclerosis inferred from GWAS. Ann Clin Transl Neurol 2019;6:1053-61. [PMID: 31211169 DOI: 10.1002/acn3.786] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
13 Ballerini C, Aldinucci A, Luccarini I, Galante A, Manuelli C, Blandina P, Katebe M, Chazot PL, Masini E, Passani MB. Antagonism of histamine H4 receptors exacerbates clinical and pathological signs of experimental autoimmune encephalomyelitis. Br J Pharmacol 2013;170:67-77. [PMID: 23735232 DOI: 10.1111/bph.12263] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
14 Larochelle C, Alvarez JI, Prat A. How do immune cells overcome the blood-brain barrier in multiple sclerosis? FEBS Lett 2011;585:3770-80. [PMID: 21550344 DOI: 10.1016/j.febslet.2011.04.066] [Cited by in Crossref: 208] [Cited by in F6Publishing: 200] [Article Influence: 18.9] [Reference Citation Analysis]
15 Girolamo F, Coppola C, Ribatti D. Immunoregulatory effect of mast cells influenced by microbes in neurodegenerative diseases. Brain, Behavior, and Immunity 2017;65:68-89. [DOI: 10.1016/j.bbi.2017.06.017] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 6.4] [Reference Citation Analysis]
16 Kallweit U, Aritake K, Bassetti CL, Blumenthal S, Hayaishi O, Linnebank M, Baumann CR, Urade Y. Elevated CSF histamine levels in multiple sclerosis patients. Fluids Barriers CNS 2013;10:19. [PMID: 23659456 DOI: 10.1186/2045-8118-10-19] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
17 Passani MB, Ballerini C. Histamine and neuroinflammation: insights from murine experimental autoimmune encephalomyelitis. Front Syst Neurosci 2012;6:32. [PMID: 22563309 DOI: 10.3389/fnsys.2012.00032] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
18 Funke U, Vugts DJ, Janssen B, Spaans A, Kruijer PS, Lammertsma AA, Perk LR, Windhorst AD. 11 C-labeled and 18 F-labeled PET ligands for subtype-specific imaging of histamine receptors in the brain: PET ligands for histamine receptors in the brain. J Label Compd Radiopharm 2013;56:120-9. [DOI: 10.1002/jlcr.3038] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
19 Imeri F, Stepanovska Tanturovska B, Zivkovic A, Enzmann G, Schwalm S, Pfeilschifter J, Homann T, Kleuser B, Engelhardt B, Stark H, Huwiler A. Novel compounds with dual S1P receptor agonist and histamine H3 receptor antagonist activities act protective in a mouse model of multiple sclerosis. Neuropharmacology 2021;186:108464. [PMID: 33460688 DOI: 10.1016/j.neuropharm.2021.108464] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Eissa N, Jayaprakash P, Azimullah S, Ojha SK, Al-Houqani M, Jalal FY, Łażewska D, Kieć-Kononowicz K, Sadek B. The histamine H3R antagonist DL77 attenuates autistic behaviors in a prenatal valproic acid-induced mouse model of autism. Sci Rep 2018;8:13077. [PMID: 30166610 DOI: 10.1038/s41598-018-31385-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
21 Pacheco R, Contreras F, Zouali M. The dopaminergic system in autoimmune diseases. Front Immunol. 2014;5:117. [PMID: 24711809 DOI: 10.3389/fimmu.2014.00117] [Cited by in Crossref: 87] [Cited by in F6Publishing: 81] [Article Influence: 10.9] [Reference Citation Analysis]
22 Biswas S, Benedict SH, Lynch SG, LeVine SM. Potential immunological consequences of pharmacological suppression of gastric acid production in patients with multiple sclerosis. BMC Med 2012;10:57. [PMID: 22676575 DOI: 10.1186/1741-7015-10-57] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
23 González H, Pacheco R. T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases. J Neuroinflammation 2014;11:201. [PMID: 25441979 DOI: 10.1186/s12974-014-0201-8] [Cited by in Crossref: 114] [Cited by in F6Publishing: 104] [Article Influence: 14.3] [Reference Citation Analysis]
24 Belfilali I, Louhibi S, Mahboub R, Touzani R, El Kadiri S, Roisnel T. Study of the histamine copper(II) chloride complex catalytic activity. Res Chem Intermed 2015;41:1819-31. [DOI: 10.1007/s11164-013-1314-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Sharma HS, Patnaik R, Muresanu DF, Lafuente JV, Ozkizilcik A, Tian ZR, Nozari A, Sharma A. Histaminergic Receptors Modulate Spinal Cord Injury-Induced Neuronal Nitric Oxide Synthase Upregulation and Cord Pathology: New Roles of Nanowired Drug Delivery for Neuroprotection. Nanomedicine in Central Nervous System Injury and Repair. Elsevier; 2017. pp. 65-98. [DOI: 10.1016/bs.irn.2017.09.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
26 Pashaei S, Yarani R, Mohammadi P, Emami Aleagha MS. The potential roles of amino acids and their major derivatives in the management of multiple sclerosis. Amino Acids 2022. [PMID: 35471671 DOI: 10.1007/s00726-022-03162-4] [Reference Citation Analysis]
27 Barkauskas DS, Dixon Dorand R, Myers JT, Evans TA, Barkauskas KJ, Askew D, Purgert R, Huang AY. Focal transient CNS vessel leak provides a tissue niche for sequential immune cell accumulation during the asymptomatic phase of EAE induction. Exp Neurol 2015;266:74-85. [PMID: 25708987 DOI: 10.1016/j.expneurol.2015.02.018] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
28 Dolati S, Babaloo Z, Jadidi-Niaragh F, Ayromlou H, Sadreddini S, Yousefi M. Multiple sclerosis: Therapeutic applications of advancing drug delivery systems. Biomed Pharmacother 2017;86:343-53. [PMID: 28011382 DOI: 10.1016/j.biopha.2016.12.010] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
29 Gebregiworgis T, Massilamany C, Gangaplara A, Thulasingam S, Kolli V, Werth MT, Dodds ED, Steffen D, Reddy J, Powers R. Potential of urinary metabolites for diagnosing multiple sclerosis. ACS Chem Biol 2013;8:684-90. [PMID: 23369377 DOI: 10.1021/cb300673e] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
30 Pino-Ángeles A, Reyes-Palomares A, Melgarejo E, Sánchez-Jiménez F. Histamine: an undercover agent in multiple rare diseases? J Cell Mol Med 2012;16:1947-60. [PMID: 22435405 DOI: 10.1111/j.1582-4934.2012.01566.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
31 Al-soqeer AA, Alsubaie QD, Motawei MI, Mousa HM, Abdel-salam AM. Isolation and identification of allergens and biogenic amines of Prosopis juliflora genotypes. Electronic Journal of Biotechnology 2017;30:24-32. [DOI: 10.1016/j.ejbt.2017.08.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
32 Shi Y, Li Z, Chen R, Zhang J, Hu X, He C, Su Q, Ma H, Ren H, Qian M, Cui S, Jiang W. Immethridine, histamine H3-receptor (H3R) agonist, alleviated experimental autoimmune encephalomyelitis via inhibiting the function of dendritic cells. Oncotarget 2017;8:75038-49. [PMID: 29088843 DOI: 10.18632/oncotarget.20500] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
33 Chen WW, Zhang X, Huang WJ. Role of neuroinflammation in neurodegenerative diseases (Review). Mol Med Rep 2016;13:3391-6. [PMID: 26935478 DOI: 10.3892/mmr.2016.4948] [Cited by in Crossref: 343] [Cited by in F6Publishing: 325] [Article Influence: 57.2] [Reference Citation Analysis]
34 Tesfaye BA, Hailu HG, Zewdie KA, Ayza MA, Berhe DF. Montelukast: The New Therapeutic Option for the Treatment of Epilepsy. J Exp Pharmacol 2021;13:23-31. [PMID: 33505173 DOI: 10.2147/JEP.S277720] [Reference Citation Analysis]
35 Igel P, Dove S, Buschauer A. Histamine H4 receptor agonists. Bioorg Med Chem Lett 2010;20:7191-9. [PMID: 21044842 DOI: 10.1016/j.bmcl.2010.10.041] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
36 Dai J, Zhang Y, Pan M, Kong L, Wang S. Development and Application of Quartz Crystal Microbalance Sensor Based on Novel Molecularly Imprinted Sol–Gel Polymer for Rapid Detection of Histamine in Foods. J Agric Food Chem 2014;62:5269-74. [DOI: 10.1021/jf501092u] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
37 Chen Y, Zhen W, Guo T, Zhao Y, Liu A, Rubio JP, Krull D, Richardson JC, Lu H, Wang R. Histamine Receptor 3 negatively regulates oligodendrocyte differentiation and remyelination. PLoS One 2017;12:e0189380. [PMID: 29253893 DOI: 10.1371/journal.pone.0189380] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
38 Doñas C, Carrasco M, Fritz M, Prado C, Tejón G, Osorio-Barrios F, Manríquez V, Reyes P, Pacheco R, Bono MR, Loyola A, Rosemblatt M. The histone demethylase inhibitor GSK-J4 limits inflammation through the induction of a tolerogenic phenotype on DCs. J Autoimmun 2016;75:105-17. [PMID: 27528513 DOI: 10.1016/j.jaut.2016.07.011] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 6.8] [Reference Citation Analysis]
39 Barata-Antunes S, Cristóvão AC, Pires J, Rocha SM, Bernardino L. Dual role of histamine on microglia-induced neurodegeneration. Biochim Biophys Acta Mol Basis Dis 2017;1863:764-9. [PMID: 28057587 DOI: 10.1016/j.bbadis.2016.12.016] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 5.2] [Reference Citation Analysis]
40 Ghalamfarsa G, Mahmoudi M, Mohammadnia-Afrouzi M, Yazdani Y, Anvari E, Hadinia A, Ghanbari A, Setayesh M, Yousefi M, Jadidi-Niaragh F. IL-21 and IL-21 receptor in the immunopathogenesis of multiple sclerosis. J Immunotoxicol 2016;13:274-85. [PMID: 26507681 DOI: 10.3109/1547691X.2015.1089343] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
41 De Bock M, Wang N, Decrock E, Bol M, Gadicherla AK, Culot M, Cecchelli R, Bultynck G, Leybaert L. Endothelial calcium dynamics, connexin channels and blood-brain barrier function. Prog Neurobiol 2013;108:1-20. [PMID: 23851106 DOI: 10.1016/j.pneurobio.2013.06.001] [Cited by in Crossref: 98] [Cited by in F6Publishing: 95] [Article Influence: 10.9] [Reference Citation Analysis]
42 Hogan A, Crean C, Barrett UM, Guihen E, Glennon JD. Histamine determination in human urine using sub-2 μm C18 column with fluorescence and mass spectrometric detection: Liquid Chromatography. J Sep Science 2012;35:1087-93. [DOI: 10.1002/jssc.201101045] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
43 Constantinescu CS, Farooqi N, O’Brien K, Gran B. Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br J Pharmacol. 2011;164:1079-1106. [PMID: 21371012 DOI: 10.1111/j.1476-5381.2011.01302.x] [Cited by in Crossref: 620] [Cited by in F6Publishing: 613] [Article Influence: 62.0] [Reference Citation Analysis]
44 Galeotti N, Sanna MD, Ghelardini C. Pleiotropic effect of histamine H4 receptor modulation in the central nervous system. Neuropharmacology 2013;71:141-7. [PMID: 23583928 DOI: 10.1016/j.neuropharm.2013.03.026] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 4.1] [Reference Citation Analysis]
45 Ghalamfarsa G, Hojjat-farsangi M, Mohammadnia-afrouzi M, Anvari E, Farhadi S, Yousefi M, Jadidi-niaragh F. Application of nanomedicine for crossing the blood–brain barrier: Theranostic opportunities in multiple sclerosis. Journal of Immunotoxicology 2016;13:603-19. [DOI: 10.3109/1547691x.2016.1159264] [Cited by in Crossref: 22] [Cited by in F6Publishing: 4] [Article Influence: 3.7] [Reference Citation Analysis]
46 Safarzadeh E, Jadidi-Niaragh F, Motallebnezhad M, Yousefi M. The role of adenosine and adenosine receptors in the immunopathogenesis of multiple sclerosis. Inflamm Res 2016;65:511-20. [PMID: 26960979 DOI: 10.1007/s00011-016-0936-z] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
47 Bahadur S, Pardhi DM, Rautio J, Rosenholm JM, Pathak K. Intranasal Nanoemulsions for Direct Nose-to-Brain Delivery of Actives for CNS Disorders. Pharmaceutics 2020;12:E1230. [PMID: 33352959 DOI: 10.3390/pharmaceutics12121230] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
48 Krone B, Grange JM. Is a hypothetical melanoma-like neuromelanin the underlying factor essential for the aetiopathogenesis and clinical manifestations of multiple sclerosis? BMC Neurol 2013;13:91. [PMID: 23865526 DOI: 10.1186/1471-2377-13-91] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
49 Wang Z, Wu J, Wu S, Bao A. High-performance liquid chromatographic determination of histamine in biological samples: The cerebrospinal fluid challenge – A review. Analytica Chimica Acta 2013;774:1-10. [DOI: 10.1016/j.aca.2012.12.041] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
50 Yilmaz UT, Inan D. Quantification of histamine in various fish samples using square wave stripping voltammetric method. J Food Sci Technol 2015;52:6671-8. [PMID: 26396415 DOI: 10.1007/s13197-015-1748-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
51 Morin F, Singh N, Mdzomba JB, Dumas A, Pernet V, Vallières L. Conditional Deletions of Hdc Confirm Roles of Histamine in Anaphylaxis and Circadian Activity but Not in Autoimmune Encephalomyelitis. J Immunol 2021;206:2029-37. [PMID: 33846226 DOI: 10.4049/jimmunol.2000719] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Sharma A, Muresanu DF, Patnaik R, Menon PK, Tian ZR, Sahib S, Castellani RJ, Nozari A, Lafuente JV, Buzoianu AD, Skaper SD, Bryukhovetskiy I, Manzhulo I, Wiklund L, Sharma HS. Histamine H3 and H4 receptors modulate Parkinson's disease induced brain pathology. Neuroprotective effects of nanowired BF-2649 and clobenpropit with anti-histamine-antibody therapy. Prog Brain Res 2021;266:1-73. [PMID: 34689857 DOI: 10.1016/bs.pbr.2021.06.003] [Reference Citation Analysis]
53 Corrêa MF, Varela MT, Balbino AM, Torrecilhas AC, Landgraf RG, Troncone LRP, Fernandes JPDS. 1-[(2,3-Dihydro-1-benzofuran-2-yl) methyl]piperazines as novel anti-inflammatory compounds: Synthesis and evaluation on H3 R/H4 R. Chem Biol Drug Des 2017;90:317-22. [PMID: 28109127 DOI: 10.1111/cbdd.12947] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
54 Costanza M. Type 2 Inflammatory Responses in Autoimmune Demyelination of the Central Nervous System: Recent Advances. J Immunol Res 2019;2019:4204512. [PMID: 31205957 DOI: 10.1155/2019/4204512] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]